Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers

Tuija Hienonen, Reijo Salovaara, Jukka-Pekka Mecklin, Heikki J Järvinen, Auli Karhu, Lauri A Aaltonen

    Research output: Contribution to journalArticleScientificpeer-review

    Original languageEnglish
    JournalInternational Journal of Cancer
    Volume118
    Issue number2
    Pages (from-to)505-508
    Number of pages4
    ISSN0020-7136
    DOIs
    Publication statusPublished - 2006
    MoE publication typeA1 Journal article-refereed

    Fields of Science

    • 311 Basic medicine

    Cite this

    @article{fd5e805c5af24dcb98d21f860f1b83f9,
    title = "Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers",
    keywords = "311 Basic medicine",
    author = "Tuija Hienonen and Reijo Salovaara and Jukka-Pekka Mecklin and J{\"a}rvinen, {Heikki J} and Auli Karhu and Aaltonen, {Lauri A}",
    year = "2006",
    doi = "10.1002/ijc.21344",
    language = "English",
    volume = "118",
    pages = "505--508",
    journal = "International Journal of Cancer",
    issn = "0020-7136",
    publisher = "Wiley",
    number = "2",

    }

    Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers. / Hienonen, Tuija; Salovaara, Reijo; Mecklin, Jukka-Pekka; Järvinen, Heikki J; Karhu, Auli; Aaltonen, Lauri A.

    In: International Journal of Cancer, Vol. 118, No. 2, 2006, p. 505-508.

    Research output: Contribution to journalArticleScientificpeer-review

    TY - JOUR

    T1 - Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers

    AU - Hienonen, Tuija

    AU - Salovaara, Reijo

    AU - Mecklin, Jukka-Pekka

    AU - Järvinen, Heikki J

    AU - Karhu, Auli

    AU - Aaltonen, Lauri A

    PY - 2006

    Y1 - 2006

    KW - 311 Basic medicine

    U2 - 10.1002/ijc.21344

    DO - 10.1002/ijc.21344

    M3 - Article

    VL - 118

    SP - 505

    EP - 508

    JO - International Journal of Cancer

    JF - International Journal of Cancer

    SN - 0020-7136

    IS - 2

    ER -